Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease
Stopped Neurogen acquired by Ligand Pharmaceuticals - no further support for study. No safety concerns identified.
Conditions
Interventions
- DRUG: aplindore MR tablets or Placebo
Sponsor
Neurogen Corporation